Search research articles
Contact Us
Filters
Showing results (111-120 of 128) with videos related to
Page
of 13
Sort By:
International Journal of Cancer
|
November 15, 1986
Binding of oestradiol to blood proteins and aetiology of breast cancer
J W Moore, G M Clark, S A Hoare, et al.
Cancer
|
August 1, 1979
Plasma IgA, IgG and IgM and their relationship to breast cancer in British, Japanese and Hawaiian-Japanese women
D Y Wang, P R Goodwin, R D Bulbrook, et al.
International Journal of Epidemiology
|
April 1, 1992
Relationship of blood prolactin levels and the risk of subsequent breast cancer
D Y Wang, B L De Stavola, R D Bulbrook, et al.
Journal of Clinical Epidemiology
|
July 1, 1995
Serum prolactin levels and their relationship to survival in women with operable breast cancer
D Y Wang, K A Stepniewska, D S Allen, et al.
International Journal of Epidemiology
|
June 1, 1990
Relationship of mammographic parenchymal patterns with breast cancer risk factors and risk of breast cancer in a prospective study
B L de Stavola, I H Gravelle, D Y Wang, et al.
British Journal of Cancer
|
June 1, 1996
A prospective study of urinary oestrogen excretion and breast cancer risk
T J Key, D Y Wang, J B Brown, et al.
British Journal of Cancer
|
May 2, 2000
Urinary androgens and breast cancer risk: results from a long-term prospective study based in Guernsey
D Y Wang, D S Allen, B L De Stavola, et al.
European Journal of Cancer & Clinical Oncology
|
November 1, 1982
The response to endocrine therapy in patients with advanced breast cancer in Great Britain and Japan
J L Hayward, R D Rubens, S Sexton, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1984
A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancer
A Howell, R D Rubens, H Bush, et al.
Lancet (London, England)
|
August 11, 1984
Controlled trial of adjuvant chemotherapy with cyclophosphamide, methotrexate, and fluorouracil for breast cancer
A Howell, H Bush, W D George, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 128) with videos related to
Sort By:
Page
of 13
International Journal of Cancer
|
November 15, 1986
Binding of oestradiol to blood proteins and aetiology of breast cancer
J W Moore, G M Clark, S A Hoare, et al.
Cancer
|
August 1, 1979
Plasma IgA, IgG and IgM and their relationship to breast cancer in British, Japanese and Hawaiian-Japanese women
D Y Wang, P R Goodwin, R D Bulbrook, et al.
International Journal of Epidemiology
|
April 1, 1992
Relationship of blood prolactin levels and the risk of subsequent breast cancer
D Y Wang, B L De Stavola, R D Bulbrook, et al.
Journal of Clinical Epidemiology
|
July 1, 1995
Serum prolactin levels and their relationship to survival in women with operable breast cancer
D Y Wang, K A Stepniewska, D S Allen, et al.
International Journal of Epidemiology
|
June 1, 1990
Relationship of mammographic parenchymal patterns with breast cancer risk factors and risk of breast cancer in a prospective study
B L de Stavola, I H Gravelle, D Y Wang, et al.
British Journal of Cancer
|
June 1, 1996
A prospective study of urinary oestrogen excretion and breast cancer risk
T J Key, D Y Wang, J B Brown, et al.
British Journal of Cancer
|
May 2, 2000
Urinary androgens and breast cancer risk: results from a long-term prospective study based in Guernsey
D Y Wang, D S Allen, B L De Stavola, et al.
European Journal of Cancer & Clinical Oncology
|
November 1, 1982
The response to endocrine therapy in patients with advanced breast cancer in Great Britain and Japan
J L Hayward, R D Rubens, S Sexton, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1984
A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancer
A Howell, R D Rubens, H Bush, et al.
Lancet (London, England)
|
August 11, 1984
Controlled trial of adjuvant chemotherapy with cyclophosphamide, methotrexate, and fluorouracil for breast cancer
A Howell, H Bush, W D George, et al.
Page
of 13